Company Filing History:
2 out of 2,597 
1 out of 1,630 
1 out of 274 
Years Active: 2023-2024
Title: The Innovations of Devin McDougald in Gene Therapy
Introduction
Devin McDougald is an innovative inventor based in Philadelphia, PA, known for his significant contributions to the field of gene therapy. With two patents to his name, he is focused on developing novel treatments for ocular and peroxisomal disorders. His work is paving the way for advancements in therapeutic approaches that could improve the lives of many.
Latest Patents
McDougald's latest patents reflect his research and development expertise. The first patent is titled "Gene Therapy for Ocular Disorders," which details a method for treating ocular neuropathy using recombinant adeno-associated viral vectors. This technology includes essential nucleic acid molecules such as sequences encoding NRF2 and SIRT1, targeting both human and various animal subjects including cats, dogs, sheep, and non-human primates.
His second patent, "Gene Therapy for Treating Peroxisomal Disorders," presents methods and compositions aimed at addressing peroxisomal biogenesis disorders (PBDs). This innovation utilizes recombinant adeno-associated viruses (rAAV) to deliver nucleic acid encoding human PEX1 to host cells. The rAAVs are strategically designed with an AAV capsid, a vector genome that consists of an AAV 5' inverted terminal repeat (ITR) sequence, a promoter, and a coding sequence for human PEX1.
Career Highlights
Throughout his career, McDougald has been affiliated with prestigious institutions such as the University of Pennsylvania and the University of Southern California. His work at these universities has positioned him at the forefront of genetic research and has contributed to his successful patent portfolio.
Collaborations
McDougald has collaborated with notable professionals in his field, including Jean Bennett and Junwei Sun. These partnerships have enriched his research endeavors and facilitated significant advancements in gene therapy technologies.
Conclusion
Devin McDougald's innovative approaches to gene therapy highlight his commitment to solving pressing medical challenges. His patents for treating ocular and peroxisomal disorders signify a promising future in therapeutic options for a variety of subjects. As he continues to push the boundaries of scientific research, McDougald remains a key figure in the field of gene therapy, inspiring future innovations.